Skip to main content

LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.